Human cells enter mitosis with damaged DNA after treatment with pharmacological concentrations of genotoxic agents

• Published in: Biochemical journal Vol. 446; no. 3; p. 373
• Main Authors: Kubara, Philip M, Kernéis-Golsteyn, Sophie, Studény, Aurélie, Lanser, Brittany B, Meijer, Laurent, Golsteyn, Roy M
• Format: Journal Article
• Language: English
• Published: England 15.09.2012
• Subjects: CDC2 Protein Kinase - metabolism; Cell Cycle; Cell Cycle Proteins - metabolism; Checkpoint Kinase 1; DNA - metabolism; DNA Damage - physiology; Genome; HT29 Cells; Humans; Mitosis; Mutagens - adverse effects; Mutagens - pharmacology; Phosphorylation; Polo-Like Kinase 1; Protein Kinases - metabolism; Protein Serine-Threonine Kinases - metabolism; Proto-Oncogene Proteins - metabolism
• ISSN: 1470-8728
• DOI: 10.1042/BJ20120385

In the present paper, we report that mitosis is a key step in the cellular response to genotoxic agents in human cells. Cells with damaged DNA recruit γH2AX (phosphorylated histone H2AX), phosphorylate Chk1 (checkpoint kinase 1) and arrest in the G2-phase of the cell cycle. Strikingly, nearly all cells escape the DNA damage checkpoint and become rounded, by a mechanism that correlates with Chk1 dephosphorylation. The rounded cells are alive and in mitosis as measured by low phospho-Tyr(15) Cdk1 (cyclin-dependent kinase 1), high Cdk activity, active Plk1 (Polo-like kinase 1) and high phospho-histone H3 signals. This phenomenon is independent of the type of DNA damage, but is dependent on pharmacologically relevant doses of genotoxicity. Entry into mitosis is likely to be caused by checkpoint adaptation, and the HT-29 cell-based model provides a powerful experimental system in which to explore its molecular basis. We propose that mitosis with damaged DNA is a biologically significant event because it may cause genomic rearrangement in cells that survive genotoxic damage.